ASCO GI 2026: New data at ASCO GI show durable first-line responses with amivantamab in metastatic colorectal cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
ASCO GI 2026: New data at ASCO GI show durable first-line responses with amivantamab in metastatic colorectal cancer
Less survivable cancers receive just 19% of research funding despite causing 40% of all cancer deaths in the UK
Potential tumour-suppressing gene identified in pancreatic cancer
Gut bacteria molecule boosts lung cancer treatment response
CtDNA levels after neoadjuvant therapy may predict breast cancer recurrence better than pathologic complete response
Study finds radiation therapy administered before surgery rarely shrinks retroperitoneal sarcoma tumors
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics
Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug
A bacterial toxin can counteract colorectal cancer growth
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Blocking a cancer-related pathway helps reduce spine deformities due to genetic disorder, finds new study
Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug